Novo Posts 14% Profit Growth Through September, Raises Annual Forecast
Danish pharmaceutical company Novo reported profit growth of 14% through September and raised its annual forecasts.
Related stories
Avista Q3 2026 Non-GAAP Utility EPS Rises to $0.38
Avista reported Q3 2026 non-GAAP utility EPS of $0.38, compared with $0.37 in Q3 2025.
L impact | EARNINGS | Nov 04, 2026, 11:33 AM UTC
Avista Expects 2026 Utility EPS of $2.52 to $2.72
Avista expects 2026 non-GAAP utility EPS of $2.52 to $2.72, versus a FactSet estimate of $2.63.
M impact | EARNINGS | Nov 04, 2026, 11:19 AM UTC
Solstice Beats Quarterly Estimates on AI Demand, Raises Annual Outlook
Solstice reported quarterly results above expectations and raised its annual outlook, citing increased AI-driven demand.
M impact | EARNINGS | Nov 04, 2026, 11:19 AM UTC
NiCE Raises FY26 Adjusted EPS Outlook and Plans 5% Workforce Cut
The company raised its adjusted earnings guidance for fiscal 2026 while reiterating its annual adjusted revenue outlook. The supplied body is truncated before the revised EPS range
M impact | EARNINGS | Nov 04, 2026, 11:19 AM UTC
Solstice Boosts Annual Forecast After Quarterly Beat
Solstice raised its annual forecast after AI-driven demand contributed to a quarterly beat.
M impact | EARNINGS | Nov 04, 2026, 11:19 AM UTC
Taboola guides FY 2026 non-GAAP net income of $151M-$160M
M impact | EARNINGS | Nov 04, 2026, 11:18 AM UTC